Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,000,562 papers from all fields of science
Search
Sign In
Create Free Account
vibunazole
Known as:
1-(4-chlorophenoxy)-3,3'-dimethyl-2-(1,2,4-triazol-1-yl)methyl-2-butanol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Antifungal Agents
Triazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
T. Hiratani
,
H. Yamaguchi
The Japanese Journal of Antibiotics
1994
Corpus ID: 44706196
Using 9 strains of Candida albicans mutants resistant to either a triazole-antifungal vibunazole, an imidazole-antifungal…
Expand
1988
1988
Vibunazole and Its Enantiomers
W. Ritter
,
G. Holmwood
,
+5 authors
H. Siefert
Annals of the New York Academy of Sciences
1988
Corpus ID: 43215834
Review
1988
Review
1988
Managing fungal and viral infection in the immunocompromised host.
U. Jehn
Recent results in cancer research. Fortschritte…
1988
Corpus ID: 30672035
The increasing number of opportunistic fungal infections in neutropenic cancer patients has become of major concern. Postmortem…
Expand
1987
1987
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
C. E. Hughes
,
W. Beggs
Journal of Antimicrobial Chemotherapy
1987
Corpus ID: 6884240
Viability studies showed that fluconazole (UK-49,858) was strictly fungistatic in its activity against three strains of Candida…
Expand
1986
1986
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
M. Schaude
,
J. Meingassner
Journal of Medical and Veterinary Mycology
1986
Corpus ID: 369760
Growth of the yeast form of Sporothrix schenckii (ATCC 14804) was determined in diffusion chambers with 0.45 and 3.0 micron pore…
Expand
1985
1985
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
E. Lefler
,
D. Stevens
Journal of Antimicrobial Chemotherapy
1985
Corpus ID: 23739274
Ketoconazole, a new imidazole: Bay L9139, and a new triazole: vibunazole (Bay n7133) were compared in therapy of systemic…
Expand
1985
1985
Pharmacokinetics of vibunazole (BAY n 7133) administered orally to healthy subjects.
C. van Gulpen
,
O. Kelder
,
H. Mattie
,
J. V. D. van der Meer
,
J. V. van't Wout
Journal of Antimicrobial Chemotherapy
1985
Corpus ID: 1738589
The role of gastric acidity in the absorption of the new antifungal drug vibunazole was studied in six healthy volunteers…
Expand
Highly Cited
1985
Highly Cited
1985
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
J. Perfect
,
D. Durack
Journal of Antimicrobial Chemotherapy
1985
Corpus ID: 38199128
We studied the penetration of two imidazoles (ketoconazole and vibunazole) and two triazoles (itraconazole and UK-49,858) into…
Expand
Highly Cited
1984
Highly Cited
1984
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133…
F. Odds
,
C. Webster
,
A. Abbott
Journal of Antimicrobial Chemotherapy
1984
Corpus ID: 27203959
Nine new antifungal agents were tested for their activity in vitro in terms of relative inhibition factors (RIFs) against 26…
Expand
1984
1984
Pharmacokinetics of the oral triazole antimycotic vibunazole in animals.
W. Ritter
,
M. Plempel
Journal of Antimicrobial Chemotherapy
1984
Corpus ID: 11873861
Methods of assay of the oral triazole antimycotic vibunazole (BAY n 7133) in body fluids by GLC, HPTLC and by a microbiological…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE